These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23285069)

  • 21. Kinetics of disease progression and host response in a rat model of bubonic plague.
    Sebbane F; Gardner D; Long D; Gowen BB; Hinnebusch BJ
    Am J Pathol; 2005 May; 166(5):1427-39. PubMed ID: 15855643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Deadly Path: Bacterial Spread During Bubonic Plague.
    Gonzalez RJ; Miller VL
    Trends Microbiol; 2016 Apr; 24(4):239-241. PubMed ID: 26875618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of Tissue Destruction and Bacterial Expansion during Bubonic Plague.
    Guinet F; Avé P; Filali S; Huon C; Savin C; Huerre M; Fiette L; Carniel E
    PLoS Pathog; 2015 Oct; 11(10):e1005222. PubMed ID: 26484539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective innate cell response and lymph node infiltration specify Yersinia pestis infection.
    Guinet F; Avé P; Jones L; Huerre M; Carniel E
    PLoS One; 2008 Feb; 3(2):e1688. PubMed ID: 18301765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.
    Levy Y; Vagima Y; Tidhar A; Zauberman A; Aftalion M; Gur D; Fogel I; Chitlaru T; Flashner Y; Mamroud E
    J Infect Dis; 2016 Sep; 214(6):970-7. PubMed ID: 27402776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.
    Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK
    Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
    Andrianaivoarimanana V; Bertherat E; Rajaonarison R; Rakotondramaro T; Rogier C; Rajerison M
    BMC Pulm Med; 2018 May; 18(1):92. PubMed ID: 29843675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
    Mwengee W; Butler T; Mgema S; Mhina G; Almasi Y; Bradley C; Formanik JB; Rochester CG
    Clin Infect Dis; 2006 Mar; 42(5):614-21. PubMed ID: 16447105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioluminescent tracing of a Yersinia pestis pCD1
    Zhou Y; Zhou J; Ji Y; Li L; Tan Y; Tian G; Yang R; Wang X
    Microbes Infect; 2018 Mar; 20(3):166-175. PubMed ID: 29180033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathology of experimental plague in cats.
    Watson RP; Blanchard TW; Mense MG; Gasper PW
    Vet Pathol; 2001 Mar; 38(2):165-72. PubMed ID: 11280372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
    Randremanana RV; Raberahona M; Randria MJD; Rajerison M; Andrianaivoarimanana V; Legrand A; Rasoanaivo TF; Randriamparany R; Mayouya-Gamana T; Mangahasimbola R; Bourner J; Salam A; Gillesen A; Edwards T; Schoenhals M; Baril L; Horby P; Olliaro P
    Trials; 2020 Aug; 21(1):722. PubMed ID: 32807214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.
    Wilson CN; Vance CO; Doyle TM; Brink DS; Matuschak GM; Lechner AJ
    Innate Immun; 2012 Jun; 18(3):373-89. PubMed ID: 21862597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.
    Blisnick T; Ave P; Huerre M; Carniel E; Demeure CE
    Infect Immun; 2008 Aug; 76(8):3808-16. PubMed ID: 18505804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell transcriptomics of immune cells in lymph nodes reveals their composition and alterations in functional dynamics during the early stages of bubonic plague.
    Zhao Y; Wang T; Liu Z; Ke Y; Li R; Chen H; You Y; Wu G; Cao S; Du Z; Bai F; Yang R
    Sci China Life Sci; 2023 Jan; 66(1):110-126. PubMed ID: 35943690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic Therapy of Plague: A Review.
    Sebbane F; Lemaître N
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34065940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.